Most Recent
Interpharma won’t challenge Precedex patent validity ruling
Intellectual Property 2019-10-03 8:54 pm By Cat Fredenburgh Melbourne
Australian drug maker InterPharma will not appeal a ruling that dismissed its challenge to the validity of global pharmaceutical giant Pfizer's patent for sedative drug Precedex.
InterPharma loses bid to invalidate Pfizer’s Precedex patent
Intellectual Property 2019-06-24 11:54 am By Miklos Bolza Sydney
Global pharmaceutical giant Pfizer has successfully defended the patent for its sedative drug Precedex against a validity challenge, a big win for the drug maker after a US court found last year that its patents for a ready-to-use version of the drug were invalid for obviousness.